Fierce Pharma Asia—Merck, Eisai’s failed Lenvima trial; J&J, Legend’s CAR-T data; AstraZeneca-Samsung COVID pact

Fierce Pharma Asia—Merck, Eisai’s failed Lenvima trial; J&J, Legend’s CAR-T data; AstraZeneca-Samsung COVID pact
aliu
Fri, 12/17/2021 – 07:04